PBLS

Conviction 46HealthcareScan · Mon, Aug 10, 2026

PBLS$35.68+2.00%

ResistanceSupportVol 14Insider buy

Vol MA14 382.71K

Jun 10Jun 23Jul 6Jul 17Jul 29Aug 10

Parabilis Medicines, Inc.Biotechnologywww.parabilismed.com ↗

Price35.68

Change+2.00%

Gap+1.03%

Rel volume1.46×

Avg volume416.19K

Avg $ vol13.33M

SMA 2032.24

SMA 50—

SMA 200—

Price vs 50—

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 36.45

RSI (14)62

MACD hist0.36

MACD cross—

Stoch %K / %D85 / 84

ADX (14)27

+DI / −DI20 / 8

RSI divergence—

MACD divergence—

ATR %+7.17%

ADR %7.77%

52w high35.90

52w low25.01

From 52w high-0.61%

Above 52w low+42.66%

New 52w highNo

SqueezeOff

Bollinger width29.60%

%B0.86

Donchian pos89.04%

Donchian high36.82

Donchian low26.42

AVWAP (52w high)35.52

vs AVWAP high+0.45%

AVWAP (52w low)29.00

vs AVWAP low+23.02%

OBV trendFlat

Chaikin MF (20)0.17

Today vs 20d1.46×

Avg vol (14d)382.71K

Avg vol (20d)416.19K

Avg $ vol (20d)13.33M

Market cap—

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank86.8

1 week+5.06%

1 month+16.72%

3 months—

6 months—

1 year—

YTD+12.91%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target41.75

Target upside19.87%

Analyst ratingBuy

Institutional0.35%

Ent. value—

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out117.17M

Employees—

ListedWed, Jun 10, 2026

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction46 / 100

Pattern quality—

Tech rank86.8 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance35.24

Support26.06

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in PBLS

All disclosures →

No recent disclosed trades by Congress in PBLS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PBLS · 9 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
RA CAPITAL MANAGEMENT, L.P. Director · Voting Common Stock · 2026-07-22	Buy	47.25K	$1.4M	2026-07-22	2026-07-22
RA CAPITAL MANAGEMENT, L.P. Director · Voting Common Stock · 2026-07-21	Buy	37.72K	$1.1M	2026-07-21	2026-07-22
RA CAPITAL MANAGEMENT, L.P. Director · Voting Common Stock · 2026-07-21	Buy	21.7K	$607K	2026-07-21	2026-07-22
RA CAPITAL MANAGEMENT, L.P. Director · Voting Common Stock · 2026-07-21	Buy	6.5K	$190K	2026-07-21	2026-07-22
RA CAPITAL MANAGEMENT, L.P. Director · Voting Common Stock · 2026-07-20	Buy	98.43K	$2.7M	2026-07-20	2026-07-22
RA CAPITAL MANAGEMENT, L.P. Director · Voting Common Stock · 2026-07-20	Buy	32.99K	$914K	2026-07-20	2026-07-22
Levy Guy 10% owner · Series F Preferred Stock · 2026-06-11	Convert	527.07K	—	2026-06-11	2026-06-29
Levy Guy 10% owner · Common Stock, par value $0.0001 per share · 2026-06-11	Buy	375K	$7.5M	2026-06-11	2026-06-29
Levy Guy 10% owner · Common Stock, par value $0.0001 per share · 2026-06-11	Buy	125K	$2.5M	2026-06-11	2026-06-29
Levy Guy 10% owner · Common Stock, par value $0.0001 per share · 2026-06-11	Convert	527.07K	$5.0M	2026-06-11	2026-06-29

SEC filings

EDGAR filings in PBLS · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.